AU2002351568A1 - Nucleic acids and methods for treating ebv-positive cancers - Google Patents

Nucleic acids and methods for treating ebv-positive cancers

Info

Publication number
AU2002351568A1
AU2002351568A1 AU2002351568A AU2002351568A AU2002351568A1 AU 2002351568 A1 AU2002351568 A1 AU 2002351568A1 AU 2002351568 A AU2002351568 A AU 2002351568A AU 2002351568 A AU2002351568 A AU 2002351568A AU 2002351568 A1 AU2002351568 A1 AU 2002351568A1
Authority
AU
Australia
Prior art keywords
methods
nucleic acids
positive cancers
treating ebv
ebv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002351568A
Other versions
AU2002351568A8 (en
Inventor
Marie Chia
Henry Joseph Klamut
Jian-Hua Li
Fei-Fei Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Health Network
Original Assignee
University Health Network
University of Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Health Network, University of Health Network filed Critical University Health Network
Publication of AU2002351568A1 publication Critical patent/AU2002351568A1/en
Publication of AU2002351568A8 publication Critical patent/AU2002351568A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002351568A 2001-12-06 2002-12-06 Nucleic acids and methods for treating ebv-positive cancers Abandoned AU2002351568A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33618001P 2001-12-06 2001-12-06
US60/336,180 2001-12-06
PCT/CA2002/001870 WO2003047634A2 (en) 2001-12-06 2002-12-06 Nucleic acids and methods for treating ebv-positive cancers

Publications (2)

Publication Number Publication Date
AU2002351568A1 true AU2002351568A1 (en) 2003-06-17
AU2002351568A8 AU2002351568A8 (en) 2003-06-17

Family

ID=23314915

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002351568A Abandoned AU2002351568A1 (en) 2001-12-06 2002-12-06 Nucleic acids and methods for treating ebv-positive cancers

Country Status (2)

Country Link
AU (1) AU2002351568A1 (en)
WO (1) WO2003047634A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2712602B1 (en) * 1993-11-18 1996-02-09 Centre Nat Rech Scient Recombinant viruses, preparation and use in gene therapy.
CN1405312A (en) * 2001-01-18 2003-03-26 中山卫健生物科技有限公司 Recombinant virus capable of specific killing tumor relating to EB virus and constructing method thereof

Also Published As

Publication number Publication date
AU2002351568A8 (en) 2003-06-17
WO2003047634A2 (en) 2003-06-12
WO2003047634A3 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
AU2001283916A1 (en) Method and nucleic acids for the analysis of astrocytomas
AU2001227966A1 (en) Methods for treating tumors
AU2002327327A1 (en) Magnetic heater apparatus and method
AU2002335090A1 (en) Methods and apparatuses for identification
AU2002360721A1 (en) Controlled lighting methods and apparatus
AU2002240602A1 (en) Body heating/cooling apparatus
AU2002350109A1 (en) Methods and apparatus for cryo-therapy
AU4341502A (en) Nod2 nucleic acids and proteins
AU3560399A (en) Tumor associated nucleic acids and uses therefor
IL149029A0 (en) High mannose proteins and methods for producing the same
AU2002307749A1 (en) Composition and method for treating cancer using herpes virus
AU2002315881A1 (en) Method and device for heating preform
AU2002246695A1 (en) Three dimensional cloaking process and apparatus
AU2002225930A1 (en) Methods for treating phosphatide-containing mixtures
AU2001265394A1 (en) Method and apparatus for purifying nucleic acids
AU2002308642A1 (en) Methods for treating cancer
AU2735002A (en) Nod2 nucleic acids and proteins
AU2002321730A1 (en) Enterovirus nucleic acids and methods for detecting enterovirus
AU2001232534A1 (en) Means and method for heating
AU2001230947A1 (en) Apparatus and method for inductive heating
AU2001285155A1 (en) Polymorphic dna fragments and uses thereof
AU2002351568A1 (en) Nucleic acids and methods for treating ebv-positive cancers
AU2002305138A1 (en) Methods and materials for cancer treatment
AU2001283488A1 (en) Methods for classifying nucleic acids and polypeptides
AUPQ688900A0 (en) Heating apparatus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase